WebOct 27, 2024 · Sciwind has developed multiple proprietary technologies, including oral peptide and inhaled protein therapeutic delivery platforms and identified a series of drug candidates based on these core platform technologies. For more information, visit www.sciwindbio.com. SOURCE Hangzhou Sciwind Biosciences Co., Ltd. Posted: … WebAug 8, 2024 · HANGZHOU, China and SAN FRANCISCO, Aug. 8, 2024 /PRNewswire/ -- Sciwind Biosciences Co., Ltd., a clinical-stage biopharmaceutical company focused on discovering and developing innovative therapies to treat metabolic disease, today announced positive interim topline results from a 26-week Phase 1c/2a clinical trial of …
Sciwind Biosciences
WebJan 11, 2024 · Sciwind Biosciences Recent Patent Activity. Publication ID. Patent Title. Status. First Filing Date. Technology (CPC) Citations. AU-2024450589-A1. N- [8- (2-hydroxybenzoyl)amino]potassium octanoate crystal polymorph, and preparation method therefor and use thereof. WebAddress: Room 1802, Building 2, Hangzhou Dongbu International Business Center, Qiantang District Development Zone Hangzhou, Zhejiang, 310000 China See other … O\u0027Reilly el
Sciwind Biosciences Announces Positive Interim Results from …
WebOct 10, 2024 · HANGZHOU, China and SAN FRANCISCO, Oct. 9, 2024 /PRNewswire/ -- Sciwind Biosciences Co., Ltd., a clinical-stage biopharmaceutical company focused on discovering and developing innovative therapies to treat metabolic disease, announced today the initiation of dosing in a Phase 1 clinical trial evaluating XW014, a novel oral … WebJun 9, 2024 · HANGZHOU, China and SAN FRANCISCO, June 8, 2024 /PRNewswire/ -- Sciwind Biosciences Co., Ltd., a clinical-stage biopharmaceutical company focusing on discovering and developing innovative... WebAug 3, 2024 · HANGZHOU, China and SAN FRANCISCO, Aug. 2, 2024 /PRNewswire/ -- Sciwind Biosciences Co., Ltd., a clinical-stage biopharmaceutical company focused on … O\u0027Reilly ex